Table 1.
Main characteristics of the study population.
| All | <28 weeks GA | AGA | SGA | |
|---|---|---|---|---|
| N | 73 | 22 | 50 | 23 |
| GA (weeks) | 29.8 ± 3.0 | 26.5 ± 1.2 | 28.6 ± 2.2 | 32.6 ± 2.5*** |
| <28 wZeeks GA (%) | 22 (30) | – | 18 (36) | 4 (17) ns |
| SGA (%) | 23 (32) | 4 (18) | – | – |
| BW (g) | 1,153 ± 314 | 828 ± 156 | 1,118 ± 310 | 1,230 ± 315 |
| BW (percentile) | 33 ± 25 | 42 ± 21 | 45.6 ± 20.3 | 5.9 ± 4.6*** |
| BH (cm) | 37.0 ± 3.3 | 33.5 ± 2.0 | 36.6 ± 3.3 | 37.8 ± 3.2 |
| BH (percentile) | 34 ± 28 | 43 ± 20 | 47.5 ± 24 | 6.0 ± 6.3*** |
| BHC (cm) | 26.3 ± 3.6 | 23.5 ± 1.4 | 25.8 ± 2.6 | 27.2 ± 2.2* |
| BHC (percentile) | 36 ± 27 | 40 ± 20 | 48.0 ± 24.5 | 10.4 ± 9.8*** |
| Sex F/M | 36/37 | 10/12 | 23/27 | 13/10 |
| Antenatal steroids n (%) | 57 (78) | 18 (82) | 39 (78) | 18 (78) ns |
| Insulin therapy n (%) | 18 (25) | 12 (55) | 15 (30) | 3 (13) ns |
GA, gestational age; BW, BH, BHC, weight, height and head circumference at birth. Results expressed as mean ± standard deviation and percentage.
ns non significant
*
p < 0.05
***
p < 0.001 for comparison between AGA vs. SGA groups.